Doctors in Houston use autologous adult stem cell therapy to treat heart failure in an FDA-approved clinical trial.
More and more clinical trials are using adult stem cells for the treatment of heart failure, with consistently positive results.
A quiet yet impressive revolution is occurring within the adult stem cell industry in an unlikely location: Cleveland, Ohio.
Scientists announce promising results in the use of autologous adult stem cells for the treatment of heart damage.
A new clinical trial at the University of Wisconsin at Madison is using mesenchymal stem cells in the treatment of patients with Type 1 diabetes.
The pharmaceutical company Athersys Inc. has announced that it is seeking commercial partners for the development and testing of its stem cell and drug therapies.
The stem cell company Bioheart has announced FDA authorization to begin Phase I clinical trials for the use of adult stem cells in the treatment of heart failure.
Researchers demonstrate a new way to stimulate endogenous heart stem cells to repair damaged heart tissue.
A number of scientists have expressed concern over new clinical trials in New Zealand which began today, in which cells from newborn pigs are implanted into human volunteers for the treatment of diabetes.
Researchers announce the successful performance of the world's first cardiac stem cell procedure.